The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted ...
On May 12, 2025, the White House issued an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” that directed multiple government agencies to take ...
While they may be linked, the administration’s DTC drug coupon site is not necessarily the entirety of its MFN efforts. With the launch of TrumpRx earlier this year, Americans got their first taste of ...
MFN policies are likely to impact more than pricing, and drug companies may alter drug launch plans in the future. With the launch of TrumpRx earlier this year, Americans got their first taste of how ...
WASHINGTON, DC - SEPT. 30, 2025: President Trump shakes hands with Pfizer CEO Albert Bourla as he announces a deal with the company to lower Medicaid drug prices. The Trump administration has ...
This commentary proposes a hybrid drug pricing reform model balancing most favored nation (MFN) benchmarking with domestic negotiation strategies that drive equity-focused valuation frameworks. US ...
On May 12, 2025, President Trump issued an Executive Order entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” in which he instructed his Administration to create ...
Half of the experts, members of the Cornell Health Policy Insight Panel, indicated MFN pricing would substantially reduce net US drug prices, while half disagreed or were uncertain about the effects.
The Most Favored Nation (MFN) drug pricing policy is gaining momentum in the United States. While the policy’s breadth of implementation is still unclear, pharmaceutical manufacturers must be ready ...
Hosted on MSN
Medicare to pilot $50 copay for weight loss drugs
Starting July 2026, Medicare will pilot a GLP‑1 Bridge program offering select weight loss drugs for a flat $50 monthly copay to eligible Part D enrollees. The initiative, part of a broader Trump ...
State and federal regulators are starting to cast a disapproving eye on contracts with “most-favored nation” clauses, where big buyers of a product or service use their market clout to squeeze sellers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results